
Indian pharma wants to conquer cancer
The Daily Brief
00:00
Current trends: MAPs first, ADCs next
Akshara outlines the dominance of monoclonal antibodies now, the rising ICIs, and technical hurdles for ADCs.
Transcript
Play full episode
Akshara outlines the dominance of monoclonal antibodies now, the rising ICIs, and technical hurdles for ADCs.